Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle

Peter C D Macpherson1, Xun Wang, Daniel Goldman

  • 1Molecular and Behavioral Neuroscience Institute and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.

Insights

Myogenin (Myog) drives muscle atrophy by increasing atrophy-related genes. Inhibiting Myog signaling may offer new therapies for muscle loss due to denervation.

Area of Science:

  • Muscle physiology
  • Molecular biology
  • Biochemistry

Background:

  • Muscle inactivity leads to atrophy, a poorly understood condition.
  • Atrophy-related genes, such as Atrogin-1 and MuRF-1, are linked to muscle mass loss.
  • Muscle denervation triggers atrophy, with Myogenin (Myog) being a key induced transcription factor.

Purpose of the Study:

  • To investigate the role of Myogenin (Myog) in muscle atrophy following denervation.
  • To explore the molecular mechanisms by which Myog influences muscle mass and function.

Main Methods:

  • Utilized conditional Myog null mice to study denervation-induced muscle atrophy.
  • Analyzed muscle force, mass, and cross-sectional area in denervated soleus muscles.
  • Investigated the regulation of Atrogin-1 and MuRF-1 gene expression by Myog.

Main Results:

  • Myog expression significantly contributed to reduced muscle force, mass, and cross-sectional area in denervated soleus muscles.
  • Myog was found to mediate these effects, at least partly, by regulating Atrogin-1 and MuRF-1 gene expression.
  • Overexpression of Myog in innervated muscle stimulated Atrogin-1 gene expression and promoter activity.

Conclusions:

  • Myogenin plays a critical role in mediating denervation-induced muscle atrophy.
  • Myog's regulation of Atrogin-1 and MuRF-1 highlights its importance in muscle mass maintenance.
  • Myog and its upstream signaling pathways represent potential therapeutic targets for combating muscle atrophy.